Publications by authors named "Faith Musenge"

Claim this Profile
M
Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors.
Ryan Murray, Md Raihan Chowdhury, Nuria Roxana Botticello-Romero, Kashvi Desai, Shanmuga Reddy Chilakapati, Faith Musenge

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined CLEC2d Expression and CD58 Loss Mitigate Rejection of Allogeneic T Cells.
Lindsey J Coholan, Cisem Karaca, Faith M Musenge, Moriah L White, Adam J Camblin

J Immunother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells.
Colby R Maldini, Angelica C Messana, Paula B Bendet, Adam J Camblin, Faith M Musenge

Mol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL.
Caroline Diorio, Ryan Murray, Mark Naniong, Luis Barrera, Adam Camblin, Faith Musenge

Blood· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Susannah L Hewitt, Dyane Bailey, John Zielinski, Ameya Apte, Faith Musenge

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
Susannah L Hewitt, Ailin Bai, Dyane Bailey, Kana Ichikawa, John Zielinski, Faith Musenge

Sci Transl Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis